Advertisement
Screener

RadNet, Inc. (RDNT) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

RadNet, Inc. Capital Expenditures

RadNet, Inc. (RDNT) reported Capital Expenditures of $74.15 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-03-16

  • RadNet, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was $5.88M, a 38.61% decline year-over-year.
  • RadNet, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $17.93M, a 2.66% increase year-over-year.
  • RadNet, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $17.40M, a 17.86% decline year-over-year.
  • RadNet, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $32.94M, a 37.56% increase year-over-year.
  • RadNet, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $74.15M, a 2.73% increase from fiscal 2018.
  • RadNet, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $72.18M, a 17.68% increase from fiscal 2017.
  • RadNet, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $61.34M, a 3.52% increase from fiscal 2016.
  • RadNet, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $59.25M, a 37.91% increase from fiscal 2015.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filed
2019-12-31$5.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$23.81M
derived: sum of 2 quarters · filed 2020-03-16
$41.21M
derived: sum of 3 quarters · filed 2020-03-16
$74.15M
10-K · filed 2020-03-16
2019-09-30$17.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$35.33M
derived: sum of 2 quarters · filed 2019-11-12
$68.27M
10-Q · filed 2019-11-12
$77.85M
derived: sum of 4 quarters · filed 2020-03-16
2019-06-30$17.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$50.34M
10-Q · filed 2019-08-09
$59.93M
derived: sum of 3 quarters · filed 2020-03-16
$77.39M
derived: sum of 4 quarters · filed 2020-03-16
2019-03-31$32.94M
10-Q · filed 2019-05-10
$42.52M
derived: sum of 2 quarters · filed 2020-03-16
$59.99M
derived: sum of 3 quarters · filed 2020-03-16
$81.17M
derived: sum of 4 quarters · filed 2020-03-16
2018-12-31$9.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$27.05M
derived: sum of 2 quarters · filed 2020-03-16
$48.23M
derived: sum of 3 quarters · filed 2020-03-16
$72.18M
10-K · filed 2020-03-16
2018-09-30$17.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$38.65M
derived: sum of 2 quarters · filed 2019-11-12
$62.59M
10-Q · filed 2019-11-12
$71.12M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$21.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$45.13M
10-Q · filed 2019-08-09
$53.66M
derived: sum of 3 quarters · filed 2020-03-16
$63.82M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$23.95M
10-Q · filed 2019-05-10
$32.48M
derived: sum of 2 quarters · filed 2020-03-16
$42.63M
derived: sum of 3 quarters · filed 2020-03-16
$54.91M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$8.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$18.69M
derived: sum of 2 quarters · filed 2020-03-16
$30.96M
derived: sum of 3 quarters · filed 2020-03-16
$61.34M
10-K · filed 2020-03-16
2017-09-30$10.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$22.44M
derived: sum of 2 quarters · filed 2018-11-09
$52.81M
10-Q · filed 2018-11-09
$59.95M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$12.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$42.65M
10-Q · filed 2018-08-09
$49.79M
derived: sum of 3 quarters · filed 2019-03-18
$61.63M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$30.37M
10-Q · filed 2018-05-10
$37.51M
derived: sum of 2 quarters · filed 2019-03-18
$49.35M
derived: sum of 3 quarters · filed 2019-03-18
$67.12M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$7.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$18.98M
derived: sum of 2 quarters · filed 2019-03-18
$36.75M
derived: sum of 3 quarters · filed 2019-03-18
$59.25M
10-K · filed 2019-03-18
2016-09-30$11.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$29.61M
derived: sum of 2 quarters · filed 2017-11-09
$52.11M
10-Q · filed 2017-11-09
$56.34M
derived: sum of 4 quarters · filed 2018-03-19
2016-06-30$17.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$40.27M
10-Q · filed 2017-08-09
$44.49M
derived: sum of 3 quarters · filed 2018-03-19
$51.58M
derived: sum of 4 quarters · filed 2018-03-19
2016-03-31$22.50M
10-Q · filed 2017-05-10
$26.73M
derived: sum of 2 quarters · filed 2018-03-19
$33.81M
derived: sum of 3 quarters · filed 2018-03-19
$45.64M
derived: sum of 4 quarters · filed 2018-03-19
2015-12-31$4.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
$11.31M
derived: sum of 2 quarters · filed 2018-03-19
$23.14M
derived: sum of 3 quarters · filed 2018-03-19
$42.96M
10-K · filed 2018-03-19
2015-09-30$7.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$18.91M
derived: sum of 2 quarters · filed 2016-11-09
$38.74M
10-Q · filed 2016-11-09
$5.51M
derived: sum of 4 quarters · filed 2017-03-31
2015-06-30$11.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$31.65M
10-Q · filed 2016-08-09
-$1.58M
derived: sum of 3 quarters · filed 2017-03-31
$5.52M
derived: sum of 4 quarters · filed 2017-03-31
2015-03-31$19.83M
10-Q · filed 2016-05-10
-$13.40M
derived: sum of 2 quarters · filed 2017-03-31
-$6.30M
derived: sum of 3 quarters · filed 2017-03-31
$3.45M
derived: sum of 4 quarters · filed 2017-03-31
2014-12-31-$33.23M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-31
-$26.13M
derived: sum of 2 quarters · filed 2017-03-31
-$16.38M
derived: sum of 3 quarters · filed 2017-03-31
$669.00K
10-K/A · filed 2017-03-31
$41.74M
10-K · filed 2015-03-16
2014-09-30$7.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$16.85M
derived: sum of 2 quarters · filed 2015-11-09
$33.90M
10-Q · filed 2015-11-09
-$3.43M
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30$9.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$26.80M
10-Q · filed 2015-08-10
-$10.53M
derived: sum of 3 quarters · filed 2016-03-30
$414.00K
derived: sum of 4 quarters · filed 2016-03-30
2014-03-31$17.05M
10-Q · filed 2015-05-11
-$20.28M
derived: sum of 2 quarters · filed 2016-03-30
-$9.34M
derived: sum of 3 quarters · filed 2016-03-30
$6.09M
derived: sum of 4 quarters · filed 2016-03-30
2013-12-31-$37.33M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-03-30
-$26.38M
derived: sum of 2 quarters · filed 2016-03-30
-$10.96M
derived: sum of 3 quarters · filed 2016-03-30
$1.97M
10-K/A · filed 2016-03-30
$48.62M
10-K · filed 2014-03-17
2013-09-30$10.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$26.36M
derived: sum of 2 quarters · filed 2014-11-10
$39.29M
10-Q · filed 2014-11-10
$39.92M
10-Q · filed 2013-11-13
$5.10M
derived: sum of 4 quarters · filed 2015-03-31
2013-06-30$15.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$28.35M
10-Q · filed 2014-08-11
-$5.84M
derived: sum of 3 quarters · filed 2015-03-31
$4.09M
derived: sum of 4 quarters · filed 2015-03-31
2013-03-31$12.93M
10-Q · filed 2014-05-12
-$21.26M
derived: sum of 2 quarters · filed 2015-03-31
-$11.33M
derived: sum of 3 quarters · filed 2015-03-31
$55.00K
derived: sum of 4 quarters · filed 2015-03-31
2012-12-31-$34.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
-$24.26M
derived: sum of 2 quarters · filed 2015-03-31
-$12.87M
derived: sum of 3 quarters · filed 2015-03-31
$1.09M
10-K · filed 2015-03-31
$44.45M
10-K · filed 2013-03-18
2012-09-30$9.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
$21.32M
derived: sum of 2 quarters · filed 2013-11-13
$35.28M
10-Q · filed 2013-11-13
$3.57M
derived: sum of 4 quarters · filed 2014-03-31
2012-06-30$11.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$25.35M
10-Q · filed 2013-08-09
-$6.36M
derived: sum of 3 quarters · filed 2014-03-31
$3.01M
derived: sum of 4 quarters · filed 2014-03-31
2012-03-31$13.96M
10-Q · filed 2013-05-10
-$17.75M
derived: sum of 2 quarters · filed 2014-03-31
-$8.38M
derived: sum of 3 quarters · filed 2014-03-31
$922.00K
derived: sum of 4 quarters · filed 2014-03-31
2011-12-31-$31.71M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-31
-$22.34M
derived: sum of 2 quarters · filed 2014-03-31
-$13.04M
derived: sum of 3 quarters · filed 2014-03-31
$2.58M
10-K/A · filed 2014-03-31
$42.72M
10-K · filed 2012-03-13
2011-09-30$9.37M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-09
$18.67M
derived: sum of 2 quarters · filed 2012-11-09
$34.28M
10-Q · filed 2012-11-09
$3.64M
derived: sum of 4 quarters · filed 2013-11-13
2011-06-30$9.30M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30
$24.91M
10-Q/A · filed 2012-08-30
-$5.72M
derived: sum of 3 quarters · filed 2013-11-13
$6.59M
derived: sum of 4 quarters · filed 2013-11-13
2011-03-31$15.62M
10-Q · filed 2012-05-10
-$15.02M
derived: sum of 2 quarters · filed 2013-11-13
-$2.71M
derived: sum of 3 quarters · filed 2013-11-13
2010-12-31-$30.64M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-13
-$18.32M
derived: sum of 2 quarters · filed 2013-11-13
$2.50M
10-K/A · filed 2013-11-13
$40.29M
10-K · filed 2012-03-13
2010-09-30$12.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$33.13M
10-Q · filed 2011-11-09
2010-06-30$20.82M
10-Q · filed 2011-08-09
2009-12-31$30.75M
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70